Compare TG Therapeutics Inc (TGTX) vs Upstart Holdings Inc (UPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Upstart Holdings Inc — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Upstart Holdings Inc trades at $29.34 (market cap $2.76B). The key difference: TG Therapeutics Inc is far larger — about 3× Upstart Holdings Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Upstart Holdings Inc nearer its low. Which is the better fit depends on your goals.
| TGTX | UPST | |
|---|---|---|
Market Cap | $8.26B | $2.76B |
Sector | Health | Financials |
52-Week High | $59.06 | $84.13 |
52-Week Low | $26.39 | $24.22 |
Enterprise Value | $8.50B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Upstart Holdings Inc
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →
